Beranda › Kanker Paru › California › Pleasanton
Uji klinis Kanker Paru di Pleasanton, CA
6 studi untuk Kanker Paru mencari peserta di lokasi sekitar Pleasanton (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Kaiser Permanente Dublin, Dublin · 4 mi jauhnya
Distance-Based Exercise to Preserve Function and Prevent Disability
Menerima peserta
- Kaiser Permanente Dublin, Dublin · 4 mi jauhnya
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Menerima pesertaFase 3
- Kaiser Permanente Dublin, Dublin · 4 mi jauhnya
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Kaiser Permanente Dublin, Dublin · 4 mi jauhnya
The Vanguard Study: Testing a New Way to Screen for Cancer
Menerima pesertaSukarelawan sehat diterima
- Kaiser Permanente-Division of Research, Pleasanton
Understanding New Cachexia Subtypes Through Observational Epidemiological Research
Menerima pesertaStudi observasional
- Kaiser Permanente Northern California, Pleasanton
Uji klinis Kanker Paru di kota lain
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Washington, DC41 studi
- Arlington, VA41 studi
- Chicago, IL41 studi
- Nashville, TN40 studi
- Baltimore, MD40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Studi lain di Pleasanton
- Kanker Prostat6 studi
- Kanker Payudara6 studi
- Kanker Ovarium4 studi
- Kanker Paru Non-Sel Kecil3 studi
- Kanker Kolorektal3 studi
- Kanker (semua jenis)3 studi
- Kanker Pankreas3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.